These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

253 related articles for article (PubMed ID: 7587024)

  • 1. Bactericidal activity of cefotaxime, desacetylcefotaxime, rifampin, and various combinations tested at cerebrospinal fluid levels against penicillin-resistant Streptococcus pneumoniae.
    Cormican MG; Erwin ME; Jones RN
    Diagn Microbiol Infect Dis; 1995; 22(1-2):119-23. PubMed ID: 7587024
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro susceptibility of Streptococcus pneumoniae strains to nine beta-lactam antibiotics and the killing kinetics of cephalosporins alone and in combination with vancomycin or gentamicin.
    Marton A; Major P
    Microb Drug Resist; 1996; 2(3):361-9. PubMed ID: 9158796
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Time-kill studies of antimicrobial combinations including cefotaxime, ceftriaxone, vancomycin and meropenem against cephalosporin-resistant Streptococcus pneumoniae.
    Kim BN; Woo JH; Kim YS; Ryu J; Kim MN; Pai CH
    Chemotherapy; 2000; 46(5):303-8. PubMed ID: 10965094
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [In vitro bactericide activity of different antibiotic combinations to Streptococcus pneumoniae resistant to penicillin and cefotaxime].
    Tubau F; Liñares J; Ardanuy C; Martínez-Lacasa J; Fernández A; Cabellos C; Fernández-Viladrich P; Martín R
    Enferm Infecc Microbiol Clin; 1996 Dec; 14(10):590-5. PubMed ID: 9053000
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro killing of penicillin-susceptible, -intermediate, and -resistant strains of Streptococcus pneumoniae by cefotaxime, ceftriaxone, and ceftizoxime: a comparison of bactericidal and inhibitory activity with achievable CSF levels.
    Stratton CW; Aldridge KE; Gelfand MS
    Diagn Microbiol Infect Dis; 1995; 22(1-2):35-42. PubMed ID: 7587048
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antibiotic therapy and acute outcome of meningitis due to Streptococcus pneumoniae considered intermediately susceptible to broad-spectrum cephalosporins.
    Tan TQ; Schutze GE; Mason EO; Kaplan SL
    Antimicrob Agents Chemother; 1994 May; 38(5):918-23. PubMed ID: 8067771
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antipneumococcal activities of cefpirome and cefotaxime, alone and in combination with vancomycin and teicoplanin, determined by checkerboard and time-kill methods.
    Bajaksouzian S; Visalli MA; Jacobs MR; Appelbaum PC
    Antimicrob Agents Chemother; 1996 Sep; 40(9):1973-6. PubMed ID: 8878565
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Killing activities of trovafloxacin alone and in combination with beta-lactam agents, rifampin, or vancomycin against Streptococcus pneumoniae isolates with various susceptibilities to extended-spectrum cephalosporins at concentrations clinically achievable in cerebrospinal fluid.
    Fitoussi F; Doit C; Geslin P; Bingen E
    Antimicrob Agents Chemother; 1999 Oct; 43(10):2372-5. PubMed ID: 10508009
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MIC and time-kill study of activities of DU-6859a, ciprofloxacin, levofloxacin, sparfloxacin, cefotaxime, imipenem, and vancomycin against nine penicillin-susceptible and -resistant pneumococci.
    Visalli MA; Jacobs MR; Appelbaum PC
    Antimicrob Agents Chemother; 1996 Feb; 40(2):362-6. PubMed ID: 8834881
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antibiotic susceptibility of clinical isolates of Streptococcus pneumoniae.
    Traub WH; Leonhard B
    Chemotherapy; 1996; 42(4):240-7. PubMed ID: 8804790
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Failure of cefotaxime treatment in two children with meningitis caused by highly penicillin-resistant Streptococcus pneumoniae.
    Guibert M; Chahime H; Petit J; Odièvre M; Labrune P
    Acta Paediatr; 1995 Jul; 84(7):831-3. PubMed ID: 7549311
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Decreased susceptibility to imipenem among penicillin-resistant Streptococcus pneumoniae.
    Pikis A; Donkersloot JA; Akram S; Keith JM; Campos JM; Rodriguez WJ
    J Antimicrob Chemother; 1997 Jul; 40(1):105-8. PubMed ID: 9249211
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Susceptibility of penicillin-resistant pneumococci to eighteen antimicrobials: implications for treatment of meningitis.
    Tweardy DJ; Jacobs MR; Speck WT
    J Antimicrob Chemother; 1983 Aug; 12(2):133-9. PubMed ID: 6555189
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Effectiveness of the antibiotics chloramphenicol and rifampin in the treatment of Streptococcus pneumoniae-induced meningitis and systemic infections].
    Hernández M; Mejía GI; Trujillo H; Robledo J
    Biomedica; 2003 Dec; 23(4):456-61. PubMed ID: 14968923
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Penicillin-resistant pneumococcal meningitis in Israel.
    Steinberg T; Rachmel A; Samra Z; Ashkenazi S
    Isr J Med Sci; 1997 Nov; 33(11):757-9. PubMed ID: 9434816
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Therapy of penicillin-resistant pneumococcal meningitis.
    Schwartz MT; Tunkel AR
    Zentralbl Bakteriol; 1995 Jan; 282(1):7-12. PubMed ID: 7734832
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of antimicrobial regimens for treatment of experimental penicillin- and cephalosporin-resistant pneumococcal meningitis.
    Friedland IR; Paris M; Ehrett S; Hickey S; Olsen K; McCracken GH
    Antimicrob Agents Chemother; 1993 Aug; 37(8):1630-6. PubMed ID: 8215275
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro activity of cefepime and cefotaxime compared to six other agents against 350 penicillin-susceptible and penicillin-resistant Streptococcus pneumoniae.
    Gomez-Lus R; Navarro C; Egido P; Aspiroz C; Goñi P; Vergara Y; Garcia C; Duran E; Castillo J; Rubio MC
    J Chemother; 2000 Feb; 12(1):17-21. PubMed ID: 10768511
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Susceptibilities of 177 penicillin-susceptible and -resistant pneumococci to FK 037, cefpirome, cefepime, ceftriaxone, cefotaxime, ceftazidime, imipenem, biapenem, meropenem, and vancomycin.
    Spangler SK; Jacobs MR; Appelbaum PC
    Antimicrob Agents Chemother; 1994 Apr; 38(4):898-900. PubMed ID: 8031069
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro activities of cefotaxime, ceftriaxone, ceftazidime, cefpirome, and penicillin against Streptococcus pneumoniae isolates.
    Barry AL; Brown SD; Novick WJ
    Antimicrob Agents Chemother; 1995 Oct; 39(10):2193-6. PubMed ID: 8619565
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.